523
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Differences in cognitive performance in nondemented Parkinson’s disease: A latent profile analysis of cognitive subtypes

ORCID Icon, , ORCID Icon &
Pages 777-789 | Received 03 Oct 2017, Accepted 18 Jan 2018, Published online: 12 Feb 2018

References

  • Aarsland, D., Bronnick, K., Williams-Gray, C., Weintraub, P., Marder, K., Kulisevsky, J., … Emre, M. (2010). Mild cognitive impairment in Parkinson disease. A multicenter pooled analysis. Neurology, 72(2), 1062–1069.
  • Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson´s disease. Movement Disorders, 20(10), 1255–1263.
  • Allcock, L. M., Rowan, E. N., Steen, I. N., Wesnes, K., Kenny, R. A., & Burn, D. J. (2009). Impaired attention predicts falling in Parkinson´s disease. Parkinsonism & Related Disorders, 15(2), 110–115.
  • Alonso-Recio, L., Martín, P., Carvajal, F., Ruiz, M., & Serrano, J. M. (2013). A holistic analysis of relationship between executive function and memory in Parkinson´s disease. Journal of Clinical and Experimental Neuropsychology, 35(2), 147–159.
  • Altmann, L. J. P., & Troche, M. S. (2011). High-level language production in Parkinson´s disease: A review. Parkinson´s Disease, 2011. doi:10.4061/2011/238956
  • Benedet, M. J., & Alexandre, M. A. (1998). Test de aprendizaje Verbal España-Complutense (TAVEC). Madrid: TEA.
  • Benton, A. L., & Hamsher, K. (1978). Multilingual aphasia examination. Iowa City, IA: University of Iowa.
  • Bergman, L. R., & Magnusson, D. (1997). A person-oriented approach in research on developmental psychopathology. Development & Psychopathology, 9, 291–319.
  • Beste, C., Dziobek, I., Hielscher, H., Willemssen, R., & Falkenstein, M. (2009). Effects of stimulus-response compatibility on inhibitory processes in Parkinson´s disease. Cognitive Neuroscience, 29, 855–860.
  • Beste, C., Willemssen, R., Saft, C., & Falkenstein, M. (2010). Response inhibition subprocesses and dopaminergic pathways: Basal ganglia disease effects. Neuropsychologia, 48, 366–373.
  • Bruna, O., Duaso, N., & Herrero, M. T. (2004). Alteraciones del lenguaje y de la comunicación en la edad adulta. In: C. Junqué, O. Bruna, & M. Mataró (Eds.), Neuropsicología del lenguaje. Funcionamiento normal y patológico. Rehabilitación (pp. 127–151). Barcelona: Elseviver Masson.
  • Caviness, J. N., Driver-Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., … Adler, C. H. (2007). Defining mild cognitive impairment in Parkinson´s disease. Movement Disorders, 22(9), 1272–1277.
  • Cools, R., Stefanova, E., Barker, R. A., Robbins, T. W., & Owe, A. (2002). Dopaminergic modulation of high-level cognition in Parkinson’s disease: The role of the prefrontal cortex revealed by PET. Brain: A Journal of Neurology, 125, 584–594.
  • Crucian, G. P., Armaghani, S., Armaghani, A., Foster, P. S., Burks, D. W., Skoblar, B., … Heilman, K. M. (2010). Visual-spatial disembedding in Parkinson´s disease. Journal of Clinical and Experimental Neuropsychology, 32(2), 190–200.
  • Crucian, G. P., Barret, A. M., Schwartz, R. L., Bowers, P., Triggs, W. J., Friedman, W., & Heilman, K. M. (2000). Cognitive and vestibule-propioceptive components of spatial ability in Parkinson´s disease. Neuropsychologia, 38, 757–767.
  • Crucian, G. P., & Okun, M. S. (2003). Visual-spatial ability in Parkinson´s disease. Frontiers in Bioscience, 8, S992–S997.
  • Damholdt, M. F., Shevlin, M., Borghammer, P., Larsen, L., & Ostergaard, K. (2012). Clinical heterogeneity in Parkinson´s disease revisited: A latent profile analysis. Acta Neurologica Scandinavica, 125(5), 311–318.
  • Dujardin, K., Leentjens, A. F. G., Langlois, C., Moonen, A. J. H., Duits, A. A., Carette, A. S., & Duhamel, A. (2013). The spectrum of cognitive disorders in Parkinson´s disease: A data-driven approach. Movement Disorders, 28(2), 183–189.
  • Dujardin, K., Moonen, A. J. H., Behal, H., Defebvre, L., Duhamel, A., Duits, A. A., … Leentjens, A. F. G. (2015). Cognitive disorders in Parkinson’s disease: Confirmation of a spectrum of severity. Parkinsonism and Related Disorders, 21, 1299–1305.
  • Erro, R., Vitale, C., Amboni, M., Picillo, M., Moccia, M., Longo, K., … Barone, P. (2013). The heterogeneity of early Parkinson´s disease: A cluster analysis of newly diagnosed untreated patients. Plos One, 8(8), 1–8.
  • Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
  • Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2004). The cognitive ability of an incident cohort of Parkinson´s patients in the UK. The CamPaIGN study. Brain, 127(3), 550–560.
  • Goldman, J. G., & Litvan, I. (2011). Mild cognitive impairment in Parkinson´s disease. Minerva Medica, 102(6), 441–459.
  • Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M., & Morris, J. G. (2008). The Sydney multicenter study of Parkinson’s disease: The inevitability of dementia at 20 years. Movement Disorders, 23(6), 837–844.
  • Henry, J. D., & Crawford, J. R. (2004). Verbal fluency deficits in Parkinson’s disease: A meta-analysis. Journal of the International Neuropsychological Society: JINS, 10, 608–622.
  • Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427–442.
  • Hughes, A. J., Ben-Shlomo, Y., Daniel, S. E., & Lees, A. J. (2001). What features improve the accuracy of clinical diagnosis in Parkinson’s disease: A clinicopathologic study. 1992. Neurology, 57(10 Suppl. 3), S34–S38.
  • Izal, M., Montorio, I., Nuevo, R., Pérez-Rojo, G., & Cabrera, I. (2010). Optimising the diagnostic performance of the Geriatric Depression Scale. Psychiatry Research, 178, 142–146.
  • Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry, 79, 368–376.
  • Janvin, C. C., Larsen, J. P., Salmon, D. P., Galasko, D., Hugdahl, K., & Aarsland, D. (2006). Cognitive profiles of individual patients with Parkinson´s disease and dementia: Comparison with dementia with Lewy bodies and Alzheimer´s disease. Movement Disorders, 21, 680–684.
  • Kaplan, G. H., & Weintraub, S. (1983). Boston naming test. Philadelphia: Lea & Febiger.
  • Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with parkinson’s disease. Lancet Neurology, 9(12), 1200–1213.
  • Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013). Cognitive impairment in Parkinson´s disease: The dual syndrome hypothesis. Neurodegenerative Diseases, 11, 79–92.
  • Kehagia, A. A., Cools, R., Barker, R. A., & Robbins, T. W. (2009). Switching between abstract rules reflect disease severity but not dopaminergic status in Parkinson disease. Neuropsychologia, 47(4), 1117–1127.
  • Levy, R., & Pillon, R. (2006). Troubles cognitifs non démentiels de la maladie de Parkinson. Psychologie & NeuroPsychiatrie du Vieillisement, 4(1), 25–34.
  • Lewis, S. J., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003). Cognitive impairments in early Parkinson´s disease are accompanied by reductions in activity in frontostriatal neural circuitry. Journal of Neuroscience, 23, 6351–6356.
  • Litvan, I., Aarsland, D., Adler, C. H., Goldman, J. G., Kulisevsky, J., Mollenhauer, B., … Weintraub, D. (2011). MDS Task Force on Mild cognitive impairment in Parkinson´s disease: Critical review of PD-MCI. Movement Disorders, 26(10), 1814.1824.
  • Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., … Emre, M. (2012). Diagnostic criteria for Mild cognitive impairment in Parkinson´s disease: Movement Disorder Society Task Force Guidelines. Movement Disorders, 27(3), 349–356.
  • Magidson, J., & Vermunt, J. (2002). Latent class models for clustering: A comparison with K-means. Canadian Journal of Marketing Research, 20, 37–44.
  • Marras, C., & Lang, A. (2013). Parkinson´s disease subtypes: Lost in translation? Journal of Neurology, Neurosurgery and Psychiatry, 84, 409–415.
  • Martinez-Martin, P., Forjaz, M. J., Cubo, E., Frades, B., & De Pedro Cuesta, J. (2006). Global versus factor-related impression of severity in Parkinson’s disease: A new clinimetric index (CISI-PD). Movement Disorders, 21, 208–214.
  • Martinez-Martin, P., & Frades Payo, B. (1998). Quality of life in Parkinson’s disease: Validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. Journal of Neurology, 245(Suppl. 1), S34–S38.
  • Mavandadi, S., Nazem, S., Ten Have, T. R., Siderowf, A. D., Duda, J. E., Stern, M. B., & Weintraub, D. (2009). Use of latent variable modeling to delineate psyquiatric and cognitive profiles in Parkinson´s disease. American Journal of Geriatric and Psychiatry, 17(11), 986–995.
  • Muslimovic, D., Post, B., Speelman, J. D., & Schmand, B. (2005). Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology, 65, 1239–1245.
  • Pai, M.-C., & Chan, S. H. (2001). Education and cognitive decline in Parkinson´s disease: A study of 102 patients. Acta Neurologica Scandinavica, 103(4), 243–247.
  • Palavra, N. C., Naismith, S. L., & Lewis, S. J. (2013). Mild cognitive impairment in Parkinson´s disease: A review of current concepts. Neurology Research International, 576091. doi:10.1155/2013/576091
  • Pereira, J. B., Junqué, C., Martí, M. J., Ramírez-Ruiz, B., Bargalló, N., & Tolosa, E. (2009). Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson’s disease. Movement Disorders, 24(8), 1193–1199.
  • Pfeiffer, H. C., Lokkegaard, A., Zoetmulder, M., Friberg, L., & Werdelin, L. (2014). Cognitive impairment in early-stage non-demented Parkinson´s disease patients. Acta Neurologica Scandinavica, 129(5), 307–318.
  • Rami, L., Valls-Pedret, C., Bartrés-Faz, D., Caprile, C., Solé-Padullés, C., Castellví, M., … Molinuevo, J. L. (2011). Cognitive reserve questionnaire. Scores obtained in a healthy elderly population and in one with Alzheimer’s disease. [Cuestionario de reserva cognitiva. Valores obtenidos en población anciana sana y con enfermedad de Alzheimer]. Revista de Neurología, 52(4), 195–201.
  • Rao, S. M., Hammeke, T. A., McQuillen, M. P., Khatri, B. O., & Lloyd, D. (1984). Memory disturbance in chronic progressive multiple sclerosis. Archives of Neurology, 41(6), 620–621.
  • Reynolds, C. R. (2002). Comprehensive trail-making test. Examiner’s manual. Austin, TX: PRO-ED.
  • Robbins, T. W., & Cools, R. C. (2014). Cognitive deficits in Parkinson´s disease: A cognitive neuroscience perspective. Movement Disorders, 29(5), 597–607.
  • Schwab, R. S., & England, A. C. (1969). Projection technique for evaluating surgery in Parkinson′s disease. In F. J. Gillingham & I. M. L. Donaldson (Eds.), Third symposium on Parkinson′s disease (pp. 152–157). Edinburgh, UK: E. & S. Livingtone.
  • Siegert, R. J., Weatherall, M., Taylor, K. D., & Abernethy, D. A. (2008). A meta-analysis of performance on simple span and more complex working memory tasks in Parkinson’s disease. Neuropsychology, 22(4), 450–461.
  • Steinley, D. (2003). Local optima in K-means clustering: What you don’t know may hurt you. Psychological Methods, 8, 294–304.
  • Thenganat, M. A., & Jankovic, J. (2014). Parkinson disease subtypes. JAMA Neurology, 71(4), 499–504.
  • Thobois, S., Guillouet, S., & Broussoelle, E. (2001). Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson´s disease. Neurophysiologie Clinique, 31, 321–340.
  • Toribio-Díaz, M., & Carod-Artal, F. J. (2015). Subtipos de deterioro cognitivo leve en la enfermedad de Parkinson y factores predictores de conversión a demencia. Revista de Neurología, 61(1), 14–24.
  • Wang, J., & Wang, X. (2012). Structural equation modeling applications using mplus. Chichester: JohnWiley & Sons.
  • Watson, G. S., & Leverenz, J. B. (2010). Profile of cognitive impairment in Parkinson Disease. Brain Pathology, 20(3), 640–645.
  • Weintraub, D., Doshi, J., Koka, D., Davatzikos, C., Siderowf, A. D., Duda, J. E., … Clark, C. M. (2011). Neurodegeneration across stages of cognitive decline in Parkinson disease. Archives of Neurology, 68, 1562–1568.
  • Weschler, D. (2001). Escala de inteligencia para adultos de Weschler (WAIS-III) [Weschler intelligence scale for adults (WAIS-III)]. Madrid, Spain: TEA Ediciones.
  • Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., … Barker, R. A. (2009). The distinct cognitive syndromes of Parkinson´s disease: 5 year follow-up of the CamPaIGN cohort. Brain, 132(11), 2958–2969.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.